Store launching soon — browse the catalog and join the waitlist to be notified at launch.
✦USPS Priority Mail1–3 day delivery across the U.S.Free on orders over $200
Store launching soon — browse the catalog and join the waitlist to be notified at launch.
Your cart is empty
Cartilage-Derived Peptide Research Compound
Cartalax is a synthetic peptide studied in laboratory research for its interaction with signaling pathways involved in cartilage-related proteins and connective tissue structure. Researchers examine how it may influence biochemical processes linked to extracellular matrix components such as collagen and proteoglycans. It is commonly used in experimental studies exploring peptide activity in structural tissue and matrix regulation pathways.
🚀 Launching soon — join the waitlist to be notified when this product is available.
This product is intended strictly for laboratory research use within the United States. It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable U.S. federal, state, and local regulations.
Cartalax is a synthetic peptide complex derived from cartilage-associated protein fractions and is developed for controlled laboratory research involving connective tissue signaling systems.
In scientific literature, Cartalax is studied in experimental models examining extracellular matrix regulation, cartilage-related signaling pathways, and structural protein interaction mechanisms under in vitro and preclinical research conditions.
Cartalax is evaluated in research focused on cartilage-associated signaling pathways and extracellular matrix regulatory systems. Experimental studies examine peptide interaction within connective tissue frameworks and structural protein signaling environments under controlled laboratory conditions.
Research publications have explored its pathway-level interaction characteristics within structured experimental models.
Cartalax emerged from investigations into short peptide complexes derived from cartilage tissue research. Early experimental work examined its biochemical properties and regulatory signaling characteristics within connective tissue frameworks.
Subsequent research expanded into laboratory models exploring extracellular matrix regulation and structural pathway interaction systems.
Laboratory investigations into Cartalax have focused on cartilage-related signaling models and extracellular matrix regulatory pathways. Research frameworks evaluate peptide interaction within connective tissue systems and structural protein signaling environments under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 20mg of lyophilized Cartalax. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the peptide preparation. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides.
PubMedThe Influence of Peptides on the Morphofunctional State of Kidneys in Old Rats.
PubMedPeptide Regulation of Cells Renewal Processes in Kidney Tissue Cultures from Young and Old Animals.
PubMedRelated
Pentadecapeptide studied for angiogenesis signaling, tissue repair pathways, and cellular regeneration research
From$50.00
$60.00
Small molecule studied for metabolic regulation, NAD pathways, and cellular energy signaling
From$40.00
Dual peptide complex studied for actin signaling, tissue regeneration pathways, and recovery system research
From$80.00
Oral peptide format studied for systemic repair signaling and gastrointestinal pathway research
$140.00
